More on APLMW
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $5.79 |
|
|||
| Open | $5.98 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $0.02 | ||||
| Day Low | $0.01 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 47,246 | ||||
- Apollomics Reports Full Year 2025 Financial Results and Provides Clinical Updates and Business Progress
- Apollomics Announces Settlement of Cayman Litigation
- Apollomics remains listed on NASDAQ after compliance determination
- Apollomics Announces Continued Listing on The Nasdaq Stock Market Following Hearing Cancellation
- NASDAQ resumes trading in Apollomics shares and warrants
- Nasdaq Resumes Trading in Apollomics Inc.
- Apollomics, Inc. Company Operational Continuity Update
- Nasdaq Halts Apollomics Inc., Ltd.
Entities mentioned with APLMW
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Definitive Agreement | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- F1 | View Related Stories »
- Layoffs | View Related Stories »
- Show More...
